| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |